The joint European Forum for Good Clinical Practice (EFGCP) and MedTech Europe Working Party announced the launch of its Workshop Report and resulting “Roadmap for Medical Device Development in Europe” on March 13th 2015.
Toshiba Medical Systems Europe today announced that it has signed a European Union-wide reseller agreement with French radiology manufacturer, Apelem, to market Xantara, a remote controlled, digital radiography and fluoroscopy (RF) system developed for Toshiba Medical Systems Europe.
The growing use of clinical and non-clinical information systems, including patient administration systems, scheduling and billing, is fuelling the demand for electronic health record (EHR) technology in Europe. EHR and ePrescribing are now priority areas in digital health across Europe, accounting for 30 percent of total healthcare IT spending in the region.
The global Magnetic Resonance Imaging (MRI) systems market will more than double in value from approximately $4.1 billion in 2013 to over $9.2 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 11.8%, according to research and consulting firm GlobalData.
As healthcare systems across the globe churn out imaging scans in larger numbers, the need for advanced visualization (AV) solutions that enable physicians to effectively visualize and analyze examination results is rising. In the face of growing diagnostic workloads in Western Europe, AV solutions help physicians arrive at accurate diagnoses of pathologies, thereby enhancing patient management.
The Americas' mammography systems market value will increase from approximately $390 million in 2013 to $1.1 billion by 2020, driven primarily by the uptake of 3D systems in the US and healthy demand for 2D systems in Canada, Mexico and Brazil.
We are seeing great priority shifts in China’s funding for R&D and manufacturing expansion. Even the agency responsible for selecting the recipients has changed, Jie Ren reports from the Beijing-based market analysis consultancy Whitney Research Inc. Report: John Brosky
A report examining the marketing communications channels available to device manufacturers today, by TforG for Encompass Content Solutions, was compiled from results of numerous interviews with device industry leaders, including senior managers in sales, marketing, operations and health care providers – from medical practitioners to hospital staff and hospital administrators.
Vygon, the specialist single-use medical devices group, today announces its acquisition of Medwin, a company based in southern France, specialized in enteral nutrition (feeding pumps) and related accessories.
Frost & Sullivan Life Sciences Senior Research Analyst Sriram Radhakrishnan discusses the available screening options to enable early detection of the virus.
Beckman Coulter, an indirect wholly-owned subsidiary of Danaher Corporation (NYSE:DHR), announced today that it has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics.
John Power is breathing easier after agreeing to let the Philips Home Healthcare deal with the complex and competitive consumer market for medical technology.
Two companies with similar core values, providing high quality products for acute care and point-of-care testing worldwide.
Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, announced that the company has reached an agreement with Medtronic to settle all outstanding patent litigation between the companies, including cases related to transcatheter heart valves.
Since opening as an exhibition in 1980, to stimulate the non-existing domestic medical device industry, the Korea International Medical & Hospital Equipment Show (KIMES) has developed to become one of the most important exhibitions for medical and healthcare industries in Northeast Asia.
The not-for-profit Chicago-based organisation HIMSS aims to boost electronic health records, analytics, mobile and other technologies by ‘meaningful use’ or other financial stimuli. Cornelia Wels-Maug reports on highlights at the HIMSS 14 conference and exhibition.
imec, the European research centre for nanoelectronics, has linked with Johns Hopkins University in Baltimore, USA, to develop the next generation of highly miniaturised medical tools.
Facing rapidly rising costs, a third (33 percent) of European hospitals are reporting operating losses, generating negative earnings after tax, according to a new nine-country study released by Accenture at the annual WoHIT Conference.
Created by the Dutch industrialist family Hilekes, in 1993 Medicor expanded beyond the Benelux countries to enter the German-speaking world as Medicor Germany GmbH, selling contrast media injectors for CT, MRI and angiography.
"I can count on my fingers the number of pathologists who work full digitally," said Elin Kindberg who is leading the development of a pathology PACS for Sectra Imaging IT Solutions. Conventional light microscopes continued to be standard tool for examining histo-pathology slides.
However, investments in equipment and advanced training are attracting medical students, John Brosky reports
Among the big players in retailing specialist medical products in the German healthcare market, Henry Schein Medical GmbH is one of around 40 subsidiaries of Henry Schein Inc. based in Melville, New York. The firm’s medical, dental and veterinary sectors are represented in 14 European countries.
Despite a slight drop in sales in 2013 compared to the previous year, for 2014 the German medical diagnostics manufacturers anticipate a positive business development, according to the trend indicator presented by the business association Verband der Diagnostika-Industrie (VDGH) in Berlin.
GE and Thermo Fisher Scientific announced yesterday that they have entered into an agreement for GE Healthcare to acquire Thermo Fisher’s HyClone cell culture media and sera, and gene modulation and magnetic beads businesses for approximately $1.06 billion.
RSNA opens a window for one week where companies can showcase the latest technologies ahead of regulatory approval. Fujifilm seized this opportunity to introduce the leading edge in tomosynthesis, the Amulet Innovality that it has launched in Europe, and that once given the green light by the FDA will come to America under the name Aspire Cristalle.